JPRN-UMIN000013251已完成2 期
Immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy. - Immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) active infectious diseases 2)Severe Complications, including Heart failure, Renal faiure, Hapatic failure, ileus, uncontrolable DM, and so on 3)Other severe problems unsuitable for this study active infectious diseases
研究者
相似试验
已完成
1 期
WT1 peptide vaccination for pediatric patients: phase I/II study.pediatric malignant tumor, hematological malignancyJPRN-UMIN000013252Osaka University Graduate School of Medicine20
已完成
1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against malignant bone and soft tissue tumors: A phase I/II studyMalignant bone and soft tissue tumorsJPRN-UMIN000010257Department of Orthopaedic Surgery, Kochi Medical School20
已完成
不适用
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against Head and Neck Tumor: A phase I/II studyHead and Neck TumorJPRN-UMIN000001906Anti-tumor Immunotherapy Research Network, Department of Immunology, Kochi Medical School65
招募中
1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against recurrent prostate cancer: A phase I/II studyProstate cancerJPRN-UMIN000001821Department of Immunology, Kochi University School of Medicine60
招募中
1 期
Immunotherapy using WT1 peptide with surgical treatment, irradiation therapy, and Temozolomide administration against glioblastoma multiforme: A phase I/II study.glioblastoma multiformeJPRN-UMIN000002419Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School45